Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Creo’s advanced energy devices are commercially available and have been used in over 5,000 procedures globally. The company’s Speedboat UltraSlim has seen rapid adoption for minimally invasive resections. The MicroBlate Flex has enabled the world’s first robotic-guided lung tissue ablation. Clinical results highlight improved patient outcomes with low recurrence rates (<1%) and shorter procedure times.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creo Medical.